Discovery and Development of Monoclonal Antibodies Targeting Tumor Neo-EpitopesTuesday, 29 October 2019 at 10:00 Add to Calendar ▼2019-10-29 10:00:002019-10-29 11:00:00Europe/LondonDiscovery and Development of Monoclonal Antibodies Targeting Tumor Neo-EpitopesImmuno-Oncology Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com An allogeneic cancer vaccine developed from human tumors surgically resected had demonstrated anti-tumor responses in a clinical trial. These responses correlated with the ability of patients to mount and sustain antibody responses against the vaccine. This vaccine was utilized as a platform to identify monoclonal antibodies with tumor sensitivity, specificity and anti-tumor killing. |